This time its personal!
Personalised medicine approaches in improving patient outcomes and reducing AMR
13 & 14 December 2022
Welcome to the BSAC Winter Conference: Infection 2022.
The recorded content from this online conference can be viewed below.
Abstracts from this conference are now published and available to view open access here
This conference is RCPath CPD accredited.
Programme
0955
Welcome and opening remarks
David Jenkins Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
OPENING LECTURE
Chair: David Jenkins Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
1000
Personalised medicine: The future for combatting AMR?
Mathew Stracy, Sir Henry Dale Fellow, University of Oxford - View Bio
SESSION ONE: Diagnostics
Chair: Nick Brown, Consultant Medical Microbiologist, Cambridge University Hospitals NHS Trust - View Bio
-
This video consists of the following presentations
-
Telemicrobiology – microbiologists across borders
David Jenkins Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
-
Longitude Prize - what happened, what happens next and lessons learnt
Jasmin Major, Programme Manager - Longitude Prize, Challenge Works - View Bio
-
Antimicrobial Susceptibility Testing
Phillipa Burns, Principal Clinical Scientist (HSST), Hull University Teaching Hospitals NHS Trust - View Bio
-
Diagnostics as part of a robust AMR Programme - Mini-BRONCHOALVEOLAR LAVAGE - The CARDIFF and Vale UHB experience - Presentation supported by Avanos
Paul Twose, Consultant Therapist for Critical Care, Cardiff & Vale UHB Honorary lecturer, Cardiff University ACPRC Critical Care Champion National Rehabilitation Collaborative Deputy Chair
-
Q&A
SESSION TWO: The patient, the clinician, and the politician: the impact of a multi-drug resistant infection
Chair: Michael Corley, Head of :Policy & Public Affairs, BSAC
-
This video consists of the following presentations
-
Fireside discussion between Lyndsay Watterson, MRSA patient; Mark Wilcox, Microbiologist and Julian Sturdy, MP on the personal, clinical and political impact of managing multi-drug resistant infections.
Lyndsay Watterson - View Bio
Mark Wilcox, Leeds Teaching Hospitals NHS Trust - View Bio
Julian Sturdy MP - View Bio
SESSION FOUR: Telehealth
Chair: Louise Sweeney, Consultant Medical Microbiologist, Manchester University NHS Foundation Trus - View Bio
-
This video consists of the following presentations
-
Telehealth - here to stay? Lessons from the UK, Australia and the US
Malcolm Fisk, Professor of Ageing and Digital Health, De Montfort University, Leicester - View Bio
-
Antimicrobial prescribing in the Telehealth setting: Framework for Stewardship during a period of rapid acceleration within primary care
Kerry L. LaPlante, Professor and Chairperson of Pharmacy, University of Rhode Island, USA - View Bio
-
The New Real World: Tech advances to improve telehealth infection management
Tom Ashfield, Senior Medical Affairs Advisor – Infection, antimicrobial resistance and stewardship, Pfizer Hospital Business Unit - View Bio
-
Q&A
SESSION SIX Clinical conundrums: Experts in the spotlight
Chair: Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC - View Bio
-
This video consists of the following presentations
-
Conundrum one: Recurrent UTI in a 56yr old man
Annie Joseph, Consultant Microbiologist, Nottingham University Hospitals NHS Trust - View Bio
-
Conundrum two: OPAT, COPAT or NOPAT?
Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
-
Panel discussion:
Panellists: Annie Joseph, Consultant Microbiologist, Nottingham University Hospitals NHS Trust; Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde & Sally Tipping, Specialist Antimicrobial Pharmacist, Royal Devon & Exeter Hospital - View Bio
SESSION SEVEN: CLINICAL LESSONS
Chair: Jacqui Sneddon, Programmes Manager, BSAC - View Bio
-
This video consists of the following presentations
-
Improving Antimicrobial Use in Older Persons Residential Care Facilities in Ireland
Mala Shah, Chief Antimicrobial Pharmacist for Community Operations, HSE, Ireland - View Bio
-
Auditing the Duration of Antibiotic Therapy for Children Treated as Inpatients for Community Acquired Pneumonia
Emma Alexander, ST2 Doctor, Barts Health NHS Trust - View Bio
-
Rapid Infection Diagnostics in Cirrhosis (RIDiC): a novel molecular-based approach to address the ever increasing challenge of antimicrobial resistant infections in decompensated cirrhosis and acute-on-chronic liver failure.
Vishal Patel, Consultant Hepatologist, Liver Unit, King's College Hospital London & Principal Investigator, The Roger Williams Institute of Hepatology, Foundation for Liver Research - View Bio
-
A novel, fast, accurate, cost-effective antimicrobial susceptibility test for urine samples
Lucy Bock, Senior Scientist/ Project Team Leader, UK Health Security Agency - View Bio
-
Q&A
SESSION EIGHT: Invited lectures
Chair: Emily Stevenson, PhD Student Antimicrobial Resistance, University of Exeter Medical School - View Bio
-
This video consists of the following presentations
-
WASH, the first cornerstone of infection management
David Berendes, Team Lead, Global WASH Epidemiology Team, Centers for Disease Control and Prevention - View Bio
-
AMR and the environment: The consequences for human health
Natalie Louise Bennett, Baroness Bennett of Manor Castle - View Bio
-
Q&A
SESSION TEN: 365 days at a time...what's new in...
Chair: Diane Ashiru-Oredope, Lead Pharmacist, HCAI, Fungal, AMR, AMU & Sepsis Division, UK Health Security Agency - View Bio
-
This video consists of the following presentations
-
Antimicrobial Stewardship – bringing AWaRe to life
Benedikt Huttner, Team Lead, Essential Medicines, World Health Organization - View Bio
-
Invasive fungal infections - tailoring treatment
Shigeru Kohno, President of Nagasaki University - View Bio
-
The role of vaccines in reducing antimicrobial resistance: progress and remaining challenges
Mateusz Hasso-Agopsowicz, Technical Officer, World Health Organization - View Bio
-
The role of procalcitonin in antibiotic stewardship - Presentation supported by Thermofisher
Neil Powell, Consultant Antimicrobial Pharmacist & Associate Director, Antimicrobial Stewardship, Royal Cornwall Hospital Trust - View Bio
-
Managing resistant Gram-negative Infections in ICU patients with HAP/VAP. Treatment options and new insights - Presentation supported by MSD
Sunny Kaul, Head of Lung Division, Consultant in ICU and Respiratory Medicine, RBHT - View Bio
-
Q&A
SESSION ELEVEN: Invited Lectures
Chair: David Jenkins Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
-
This video consists of the following presentations
-
The joint seasonal challenge of COVID19 and influenza
Jamie Lopez Bernal, Consultant Epidemiologist, UK Health Security Agency - View Bio
-
PCR based diagnosis of CPE – making the case for a better way forward
Terry Whalley, Delivery Director, NHS Lancashire and South Cumbria Integrated Care Board - View Bio
-
Social media - the good, the bad and the ugly, myths & legends. How helpful are social media influencers in driving improvements in healthcare?
Neil Stone, Consultant in Infectious Diseases and Microbiology, University College London Hospitals - View Bio
-
Q&A
SESSION TWELVE: Closing discussion
Chair: David Jenkins Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
-
This video consists of the following presentations
-
1620
Closing remarks
David Jenkins Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
